Reviewing CollPlant Biotechnologies (NASDAQ:CLGN) and Envoy Medical (NASDAQ:COCH)

CollPlant Biotechnologies (NASDAQ:CLGNGet Free Report) and Envoy Medical (NASDAQ:COCHGet Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Analyst Ratings

This is a breakdown of current ratings and target prices for CollPlant Biotechnologies and Envoy Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CollPlant Biotechnologies 0 0 1 1 3.50
Envoy Medical 0 0 3 0 3.00

CollPlant Biotechnologies presently has a consensus target price of $11.00, indicating a potential upside of 111.13%. Envoy Medical has a consensus target price of $7.25, indicating a potential upside of 140.07%. Given Envoy Medical’s higher possible upside, analysts clearly believe Envoy Medical is more favorable than CollPlant Biotechnologies.

Earnings & Valuation

This table compares CollPlant Biotechnologies and Envoy Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CollPlant Biotechnologies $689,000.00 86.60 -$7.02 million ($0.68) -7.66
Envoy Medical $302,000.00 196.00 -$29.91 million N/A N/A

CollPlant Biotechnologies has higher revenue and earnings than Envoy Medical.

Profitability

This table compares CollPlant Biotechnologies and Envoy Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CollPlant Biotechnologies -70.58% -24.74% -20.90%
Envoy Medical N/A N/A -112.11%

Insider & Institutional Ownership

21.7% of CollPlant Biotechnologies shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 9.6% of CollPlant Biotechnologies shares are owned by insiders. Comparatively, 0.7% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

CollPlant Biotechnologies has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500.

Summary

CollPlant Biotechnologies beats Envoy Medical on 7 of the 13 factors compared between the two stocks.

About CollPlant Biotechnologies

(Get Free Report)

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

About Envoy Medical

(Get Free Report)

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Receive News & Ratings for CollPlant Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CollPlant Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.